Education Library

Special Topics · Article

Seizures: Environmental Triggers Nobody Maps

EMF, excitotoxins, nutrient depletion, mold, and the environmental load that can push a susceptible nervous system into seizure activity.

Rev. Allie Johnson

Sanctified Healer · Monastic Medicine Practitioner

What Is a Seizure

Your brain communicates through electrical signals. Every thought, movement, sensation, and memory is the result of neurons firing in coordinated patterns — electrical impulses passing from cell to cell through a precisely regulated system of excitation and inhibition. The brain has two primary neurotransmitter systems governing this balance: glutamate, which is excitatory (it fires the neuron), and GABA, which is inhibitory (it quiets the neuron). In a healthy brain, these systems hold each other in dynamic equilibrium. Neurons fire when they should. They stop when they should.

A seizure happens when that balance breaks down. When the excitatory system overwhelms the inhibitory system — when too many neurons fire simultaneously, synchronously, and uncontrollably — the result is an abnormal electrical storm in the brain. Depending on where it starts and how far it spreads, the experience ranges from a brief moment of absent awareness to a full tonic-clonic convulsion. But the underlying mechanism is the same: excitation without adequate inhibition.

This is where the concept of seizure threshold becomes everything. The seizure threshold is not a fixed line. It is a dynamic balance point — the amount of neurological stress the brain can absorb before the excitatory system tips past what the inhibitory system can contain. That threshold rises and falls constantly, shaped by sleep quality, blood glucose, mineral status, hormonal state, toxic load, electromagnetic environment (voltage-gated calcium channel activation: Pall ML, J Cell Mol Med, 2013, PMID 23802580), and the structural integrity of the brain itself.

This is the most important thing no one told you: the seizure threshold is modifiable. It can be raised — by removing what is lowering it and restoring what supports it. It can also be lowered — by every environmental, nutritional, and toxic input that the standard neurology appointment does not ask about.

A medication can raise the seizure threshold pharmacologically by enhancing GABA or blocking glutamate or stabilizing ion channels. That is what anti-seizure drugs do, and for many people they are essential — they are not the problem. The question the medication alone cannot answer is why the threshold dropped. Medication and trigger identification are not opposites. They are complementary — and the trigger work is almost never done.

The question the neurology appointment doesn't ask

"What is in your bedroom? What are you eating before they happen? How much sleep did you get the night before each one? What does your EMF environment look like?"

None of those questions appear on a standard neurology intake form. What does appear: which medications have you tried, what dose, and which ones didn't work. The framework for seizure management begins with medication — and for many people, medication is essential and lifesaving. The problem is that it's often where the conversation ends.

Medication raises the seizure threshold. Trigger identification raises it further. Understanding what is actively lowering your threshold — and removing those inputs — is the part of seizure management that is almost never done. This page is about that part. It is not a reason to stop medication. It is the conversation you should also be having.

Questions you were probably not asked

Do you have a smart TV, phone, or router in the bedroom? Non-native EMF alters voltage-gated calcium channel activity in neurons — the same ion channels involved in seizure generation. A device six feet from your head all night is not a neutral presence in a brain with a lowered seizure threshold.

What did you eat in the 4 hours before the seizure? Glucose dysregulation — the post-sugar spike-and-crash cycle, skipped meals, reactive hypoglycemia — is one of the most reliable and least-mapped seizure triggers. The brain runs on glucose. When glucose drops, excitability increases.

How much sleep did you get in the 48 hours before each event? Sleep deprivation is the single most potent modifiable seizure trigger in the literature. It lowers seizure threshold across every seizure type. Neurologists know this. They rarely build an environmental sleep plan around it.

Has anyone checked your magnesium — intracellular, not just serum? Magnesium is the physiological brake on the NMDA receptor. NMDA receptor overactivation is a core mechanism in seizure generation. Magnesium depletion removes this brake. Eclamptic seizures in pregnancy are treated with intravenous magnesium. The mechanism is established. The outpatient question is almost never asked.

Do you use Bluetooth headphones or earbuds regularly? Pulsed microwave radiation from Bluetooth transmitters, placed directly in the ear canal, is in millimeter proximity to the temporal lobe — the brain region most commonly involved in focal seizure generation. This is not studied in depth. It should be. The precautionary argument is straightforward.

Have you been told that each seizure itself causes brain damage? Glutamate release during a seizure causes excitotoxic calcium influx into neurons — the same mechanism as TBI-related cell death. Hippocampal atrophy is documented in temporal lobe epilepsy from repeated seizures. The post-ictal state is the brain in injury recovery. It is not a phase to push through. It is a recovery period that must be respected.

Were you told about Sudden Unexpected Death in Epilepsy (SUDEP)? It kills an estimated 1,100–1,500 Americans per year. It is real, it is documented, and it is almost never disclosed to patients or families at diagnosis. You have the right to know this risk exists.

For children: does the seizure pattern worsen with screen time, blue light exposure, or disrupted sleep schedules? Photosensitive epilepsy affects an estimated 5% of people with epilepsy. LED and fluorescent lighting flicker at 100–120Hz in the US — a range that can trigger cortical hyperexcitability in sensitive individuals even when the light appears steady to the eye. The television in the bedroom is not a neutral object for a child with a seizure disorder.

How much time do you spend in direct sunlight? Morning sunlight anchors the circadian clock, drives the cortisol awakening response, and initiates the 12–16 hour countdown to melatonin production. Melatonin is a potent neuroprotective antioxidant — it crosses the blood-brain barrier, scavenges reactive oxygen species in neurons, and has documented anticonvulsant properties. Insufficient sun exposure means chronically low melatonin. Low melatonin means a brain with degraded overnight neuroprotection. This is never asked.

Do you sleep in a completely dark room? Any light during sleep — from a streetlight through curtains, a standby LED, a phone screen — suppresses melatonin and disrupts sleep architecture. Blue-spectrum light is the most potent suppressor, but any light at night signals "day" to the suprachiasmatic nucleus and truncates the restorative phase of the sleep cycle. For a brain with a lowered seizure threshold, the quality of the dark matters as much as the hours of sleep.

What position do you sleep in? The glymphatic system — the brain's waste clearance network — is most active during sleep and operates most efficiently in the lateral (side) position. Glymphatic flow removes excitatory metabolic byproducts including glutamate and amyloid from brain interstitial fluid. In a brain producing excess glutamate through seizure activity, glymphatic clearance is one of the primary overnight recovery mechanisms. Prone (face down) sleeping significantly impairs glymphatic flow. It is also the position most strongly associated with SUDEP risk. Sleep position is not a trivial question for someone with epilepsy.

Do you wear a smartwatch or fitness tracker? Wearable devices emit continuous low-level Bluetooth and sometimes Wi-Fi radiation in direct skin contact, 24 hours a day — including during sleep. As a source of chronic close-proximity non-native EMF, a smartwatch on the wrist all night is meaningfully different from a phone across the room. The wrist also sits directly over the radial artery — a major vascular channel. In a person with a seizure disorder already working to reduce VGCC activation from environmental EMF, a continuous Bluetooth transmitter worn while sleeping is a variable worth removing before concluding the environment is clean.

What lighting do you use in the evening? LED bulbs — now the default in nearly every home — produce a blue-shifted, high-flicker light that suppresses melatonin far more aggressively than the incandescent bulbs they replaced. The flicker from LED driver circuitry operates at 100–120Hz — invisible to conscious perception but detectable by the visual cortex. In photosensitive individuals this can directly trigger cortical hyperexcitability. In everyone with a seizure disorder, LED evening lighting is degrading the sleep that is their most important seizure-threshold variable. Swapping bedroom and evening lights to incandescent, low-flicker, or red-spectrum bulbs is one of the lowest-cost, highest-leverage changes available.

If the answer to most of those is no — this page is designed to fill that gap.

Each Seizure Is a Brain Injury

A seizure is an abnormal, synchronous electrical discharge in the brain. It is not simply an inconvenient symptom. During a generalized tonic-clonic seizure, the brain undergoes a massive excitatory surge — glutamate is released in excess, calcium floods neurons through NMDA receptors and voltage-gated calcium channels, and mitochondria in those neurons are overwhelmed. This is excitotoxicity — the same mechanism responsible for the neuronal death that follows stroke, traumatic brain injury, and hypoxic brain injury.

The post-ictal state — the hours of confusion, exhaustion, headache, and cognitive impairment that follow a seizure — is the outward manifestation of a brain in acute injury recovery. It is not a side effect of the seizure. It is the evidence that injury occurred. Forcing cognitive activity during this period is the neurological equivalent of asking someone to sprint on a freshly broken ankle.

Sudden Unexpected Death in Epilepsy (SUDEP) — What You Were Not Told

SUDEP is the most common cause of death in people with uncontrolled epilepsy. It typically occurs at night, during or shortly after a seizure, in the absence of any other cause. Risk factors include: uncontrolled generalized tonic-clonic seizures, nocturnal seizures, sleeping alone, prone sleeping position during or after a seizure, medication non-compliance, and alcohol use. Most patients are never told this risk exists. Informed consent for epilepsy management requires this disclosure.

Hippocampal atrophy — measurable shrinkage of the hippocampus from repeated excitotoxic injury — is documented in temporal lobe epilepsy. Memory, spatial navigation, and emotional regulation all depend on hippocampal integrity. Seizures that are not stopped are not events that pass harmlessly. They are events that, over time, reshape the brain's architecture.

The Environment Is Part of the Treatment

If the environmental inputs that are lowering your seizure threshold — blue light, non-native EMF, glucose instability, magnesium depletion, sleep disruption — are still present and unchanged, the medication is working harder than it needs to. Removing known threshold-lowering inputs doesn't replace medication. It makes the medication more effective, and in some cases it changes the picture enough that a medication conversation with your neurologist becomes different.

The bedroom is the place to start. A smart TV, a phone on the nightstand, a router on the other side of the wall, LED lighting, and artificial light at night all operate as neurological stressors for the hours you sleep — the same hours your brain is supposed to be clearing metabolic waste, restoring inhibitory balance, and running the glymphatic system. None of this appears on any discharge sheet.

The residential EMF environment is worth assessing.

A smart meter on the bedroom wall, a router adjacent to the sleeping space, a dense wireless environment from neighboring buildings — these are measurable exposures that are never included in a seizure workup. For people with refractory seizures who have cycled through multiple medications without adequate control, a systematic environmental assessment — bedroom EMF, blue light, sleep quality, mineral status, glucose stability — is the conversation that often has not been had. It costs very little to evaluate, and the intervention is removing things, not adding them.

Light, water, and magnetism are not fringe variables in neurological health — they are the oldest biological inputs the brain evolved with. Chronic artificial blue light disrupts melanopsin signaling in the retina, damages circadian rhythm, suppresses melatonin production, and fragments sleep architecture — all of which directly affect seizure threshold through pathways that are documented in the circadian and sleep literature. Morning sunlight exposure, genuinely dark sleep, mineralized water, and reduced electromagnetic burden at night are not alternatives to medical care. They are the environment in which medical care either succeeds or struggles.

Your Medications: Informed Consent

Anti-seizure medications (ASMs) — the preferred current term over "anticonvulsants" or "antiepileptics" — work by reducing neuronal excitability. They do this through several mechanisms: enhancing GABAergic inhibition (benzodiazepines, phenobarbital, valproate, vigabatrin), blocking voltage-gated sodium channels (phenytoin, carbamazepine, lamotrigine, oxcarbazepine), blocking calcium channels (ethosuximide, gabapentin), or reducing glutamate activity (perampanel). For many seizure types and many individuals, they work well and are important tools.

Informed consent means knowing what your medication does, what it depletes, what its known side effects are, and — where they exist — what the alternatives or adjuncts look like. Status epilepticus is a medical emergency requiring immediate intervention. Long-term daily medication for seizure control is a serious decision that deserves a serious conversation. What is almost never part of that conversation: what the medication depletes, how it interacts with your specific environmental picture, and what metabolic groundwork would make it more effective.

What is almost never checked before prescribing:

  • — Intracellular magnesium level (serum magnesium is not an accurate reflection of tissue stores)
  • — Thiamine (B1) status — thiamine deficiency causes neurological dysfunction and lowers seizure threshold; depleted by high-carbohydrate/processed food diets, alcohol, metformin, and prolonged illness
  • — Glucose variability — continuous glucose monitoring would reveal reactive hypoglycemic episodes preceding seizures in a subset of patients
  • — Zinc and taurine levels — both involved in inhibitory signaling; depleted by OCs, stress, caffeine, alcohol
  • — Hormonal status — catamenial epilepsy (seizures correlated with menstrual cycle) represents 10–70% of seizure disorders in women; estrogen is pro-convulsant, progesterone is anti-convulsant; hormonal context is almost never part of seizure workup
  • — Sleep quality and architecture — not "how many hours" but whether sleep is restorative, whether there are nocturnal awakenings, and what the sleep environment looks like
  • — EMF environment — bedroom, home, and occupational exposure
  • — Vaccine or medication temporal correlation — whether seizure onset follows a vaccination, a new medication, or an acetaminophen course

Keppra (Levetiracetam) and Behavioral Effects in Children

Levetiracetam (Keppra) is the most commonly prescribed first-line anti-seizure medication in children and adults. It is effective. It also carries a documented and significant behavioral side effect profile that is systematically under-disclosed to parents. "Keppra rage" — severe irritability, aggression, emotional dysregulation, oppositional behavior, and mood instability — is reported by families at high rates and acknowledged in the prescribing literature. The mechanism is not fully understood but likely involves Keppra's effects on synaptic vesicle protein SV2A across limbic structures.

A child who was calm before seizures and who begins exhibiting explosive aggression and emotional dysregulation after starting Keppra is not experiencing a separate psychiatric condition. They are experiencing a known, documented pharmacological effect. This is almost never the first explanation offered. It is almost always the last one considered — after the behavior has been labeled, after additional psychiatric medications have been considered, and after the family has spent months managing a child who has been made worse by the drug intended to help them.

Vitamin B6 (pyridoxine) is the rate-limiting cofactor that allows the enzyme glutamate decarboxylase (GAD) to convert excitatory glutamate into inhibitory GABA. Multiple randomized, double-blind, placebo-controlled trials have confirmed that co-administration of pyridoxine significantly improves behavioral change scores in children and adolescents on Keppra (PMID 40913882). It is almost never mentioned at the prescribing encounter. A family navigating Keppra behavioral effects deserves to know this literature exists, and to have that conversation with a physician who is aware of it.

Depakote (Valproate) — The Pregnancy and Mitochondrial Warning

Valproate carries a Black Box Warning for major congenital malformations (neural tube defects, particularly spina bifida) in pregnancy — risk is 10–20 times above background. It is also one of the most commonly prescribed long-term anti-seizure medications in women of reproductive age. It causes dose-dependent mitochondrial toxicity, depletes carnitine (required for mitochondrial fatty acid transport), causes dose-dependent liver toxicity, and produces a characteristic clinical presentation of metabolic acidosis, hyperammonemia, and hepatic failure in rare but severe cases. None of this is front-loaded in the conversation.

Valproate also depletes zinc — and zinc regulates the GABA-A receptors that valproate is trying to support. It depletes folate, compounding its already serious birth defect risk in women of childbearing age. It depletes selenium, adding oxidative stress to a liver the drug is simultaneously taxing. A medication that depletes the very nutrients its own mechanism depends on, in ways that amplify its most serious risks, deserves more than a signature on a consent form.

Lamotrigine (Lamictal) — The Rash That Can Kill

Lamotrigine carries an FDA Black Box Warning for Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) — both life-threatening reactions in which the skin blisters and separates from the body as if severely burned. Risk is highest in children and during the first eight weeks of treatment (Guberman AH et al., Neurology, 1999, PMID 10390512). The most critical risk factor is dose escalation speed — raising the dose too quickly dramatically increases the probability of this reaction. Any rash while on lamotrigine must be taken seriously and reported immediately. The FDA warning exists because this reaction has been fatal. It is not a theoretical risk.

Lamotrigine depletes folate — essential for DNA repair, neurotransmitter synthesis, and fetal neural tube development — and biotin (B7), which is required for fatty acid synthesis and gene expression. It also raises levels of certain other AEDs if co-prescribed (the interaction with valproate is particularly significant — valproate dramatically increases lamotrigine blood levels, making the dose that was safe without valproate potentially toxic with it). This is a known interaction that requires dose adjustment when both are prescribed together.

Carbamazepine (Tegretol) — The Depletion Profile

Carbamazepine is an older anticonvulsant with a narrow therapeutic window — the difference between a dose that works and a dose that becomes toxic is small. It carries a Black Box Warning for aplastic anemia (bone marrow failure — rare but potentially fatal) and Stevens-Johnson Syndrome, with higher SJS risk in patients of Han Chinese, Thai, or Malaysian ancestry due to a genetic variant (HLA-B*1502) that the prescribing conversation rarely includes genetic testing for.

It has one of the most aggressive nutrient depletion profiles on this list. Carbamazepine depletes folate, B12, biotin, sodium, and vitamin D — not as a side effect to be noted on a label, but through documented enzyme-induction mechanisms that accelerate the breakdown of these nutrients. Long-term users develop anticonvulsant osteomalacia — soft, weakened bones from calcium loss secondary to chronic vitamin D depletion. The drug prescribed to prevent seizures is gradually demineralizing the skeleton, in a way that is not typically monitored or addressed.

Phenytoin (Dilantin) — The Most Aggressive Depletion Profile

Phenytoin has been prescribed for seizures since 1938. Its therapeutic window is extremely narrow, and blood levels must be monitored closely — at levels just above therapeutic, patients develop nystagmus (involuntary eye movement), ataxia (loss of coordination), and confusion. Gingival hyperplasia — abnormal growth of gum tissue over the teeth — occurs in up to 50% of long-term users.

Its depletion profile is the most severe of any anticonvulsant on this list: vitamin D, folate, B12, calcium, Coenzyme Q10, and biotin — all depleted through enzyme induction and competitive absorption mechanisms. Depleted folate in women of reproductive age on phenytoin is a neural tube defect risk in any pregnancy. Depleted vitamin D causes calcium loss and progressive bone fragility. Depleted CoQ10 undermines mitochondrial energy production in every neuron. The medication that controls the seizure is simultaneously removing the nutrients required for brain energy stability — in ways that are not monitored in most outpatient epilepsy care.

Topiramate (Topamax) — "Dopamax" and Kidney Stones

Topiramate is prescribed for seizures, migraines, and increasingly for weight loss. Its nickname in clinical practice — "Dopamax" — reflects its most common complaint: significant cognitive dulling, word-finding difficulty, and slowed thinking that patients describe as a persistent mental fog. This is not a rare or mild effect. It is one of the most commonly reported reasons patients discontinue the medication, and it is underemphasized in the prescribing conversation.

Topiramate inhibits carbonic anhydrase — an enzyme involved in pH and fluid regulation — in the kidney, creating conditions that produce kidney stones at a rate roughly 75 times the general population in some studies. It is also associated with an increased risk of cleft palate and cleft lip in pregnancy (FDA safety communication, 2011). The depletions — folate, biotin, and CoQ10 — follow the same pattern as other anticonvulsants: the nutrients that support mitochondrial energy and inhibitory neurotransmitter synthesis are the ones going out.

Gabapentin (Neurontin) — Off-Label, Underdisclosed Withdrawal

Gabapentin was approved for epilepsy but is now prescribed far more often for nerve pain, anxiety, insomnia, and fibromyalgia — all off-label indications (not FDA-approved for those purposes). It binds to calcium channels and reduces neurotransmitter release, and it is frequently presented as well-tolerated. What is not routinely disclosed is the withdrawal syndrome.

Gabapentin produces physical dependence with regular use. Stopping abruptly causes a withdrawal syndrome that includes anxiety, insomnia, sweating, nausea, and in some cases — including in people who were not taking it for seizures — seizures. A patient who was prescribed gabapentin for back pain, who stops taking it when the pain resolves, can have a seizure from withdrawal. This risk is not front-loaded in the prescribing conversation. For a patient who already has a seizure disorder, the withdrawal risk is higher — and the interaction between gabapentin discontinuation and an existing seizure threshold is a variable that the prescribing physician may not have considered. It depletes folate, B12, and vitamin D — the same three that most anticonvulsants deplete — compounds the neurological depletion load when used alongside other AEDs.

These are the most commonly prescribed anti-seizure medications. Not every drug is covered here. To look up your specific medication — nutrient depletions, interactions, black box warnings, and post-marketing side effects — visit the Drug Library.

What Your Medication Is Doing — and the Lifestyle Equivalent

Every anti-seizure medication works by modifying a specific neurological pathway — enhancing inhibition, suppressing excitation, or stabilizing electrical activity. These same pathways are directly modifiable through environment, food, and removing what is actively disrupting them. Understanding what your medication is targeting tells you exactly where the biology is failing — and what to address from the outside.

MechanismDrugs Using ThisWhat It MeansLifestyle Correlate — The Same Target Without the Drug
GABA enhancementBenzodiazepines, phenobarbital, valproate, vigabatrin, tiagabine, clobazamThe brain's inhibitory system is insufficient. The drug amplifies GABA signaling to compensate.Taurine (seafood, meat) — positive GABA modulator. Magnesium — required for GABA synthesis and receptor function. Progesterone → allopregnanolone — the body's endogenous GABA-A positive allosteric modulator (same mechanism as benzodiazepines). Sunlight + circadian rhythm — regulate GABA/glutamate oscillation. Remove glyphosate — depletes GABA-producing gut bacteria via shikimate pathway disruption.
Glutamate / NMDA suppressionFelbamate, topiramate, lamotrigine, levetiracetam, perampanelThe excitatory system is overactive. The drug reduces glutamate availability or blocks its receptors.Magnesium — the physiological NMDA receptor block. Remove MSG, aspartame, hydrolyzed protein — eliminate dietary excitatory load. Remove fluoride — restores cholinesterase function, reduces excitatory ACh excess. Zinc — modulates NMDA receptor sensitivity. Sleep — glymphatic clearance removes excess synaptic glutamate overnight.
Sodium channel stabilizationPhenytoin, carbamazepine, lamotrigine, oxcarbazepine, lacosamideNeurons are firing too easily. The drug slows or limits sodium channel opening to reduce repetitive firing.DHA from food (wild salmon, sardines, egg yolk) — omega-3 fatty acids modulate sodium channel kinetics and membrane fluidity. Adequate minerals — sodium/potassium balance governs resting membrane potential. Remove pyrethroids (conventional produce, lawn chemicals) — prolong sodium channel opening, the exact opposite of what these drugs do.
Calcium channel modulationEthosuximide (T-type), gabapentin, pregabalin (α2δ subunit)Voltage-gated calcium channels (VGCCs) are activating too readily, triggering excitatory cascades.Remove non-native EMF — research (PMC3780531, Pall ML, J Cell Mol Med, 2013, PMID 23802580) documents that Wi-Fi, Bluetooth, and cell radiation activate VGCCs directly. Do not supplement Vitamin D — synthetic D3 raises serum calcium, increasing VGCC excitatory tone; use morning sunlight and food sources instead. Magnesium — competes with calcium at the channel pore; the physiological VGCC brake.
Neuronal energy / mitochondrialKetogenic diet (metabolic intervention), acetazolamideThe brain lacks sufficient metabolic stability to maintain inhibitory tone. Energy failure drives excitability.Thiamine (B1) from food — mitochondrial cofactor; depleted by sugar, alcohol, EMF, stress. Morning sunlight — activates cytochrome c oxidase (Complex IV), the terminal enzyme that produces neuronal ATP. Remove fluoride — directly inhibits cytochrome c oxidase. Real whole food — stable glucose removes energy floor instability.
Neuroinflammation reductionSecondary effect of several AEDs; CBD (Epidiolex)Chronic neuroinflammation lowers seizure threshold by sensitizing glutamate receptors and disrupting blood-brain barrier integrity.Remove seed oils and processed food — primary dietary driver of neuroinflammation. Remove artificial dyes and pesticides — documented inflammatory triggers. DHA from food — resolvin and protectin precursors that resolve neuroinflammation. Morning sunlight — sulfated vitamin D is anti-inflammatory via pathways supplements cannot replicate. Earthing — documented reduction in inflammatory markers (Chevalier et al., Journal of Environmental and Public Health, 2012).

This is not a table for stopping medication. It is a map of what the medication is compensating for — and what can be rebuilt so it has less to compensate for.

Tylenol, OTC Medications, and the Neuroinflammation Connection

Acetaminophen (Tylenol) depletes glutathione — the brain's primary antioxidant. This is the mechanism behind its hepatotoxicity, and it operates in the brain as well. Glutathione is required to manage the oxidative stress that follows any neuroinflammatory event, including a seizure. Giving a child Tylenol after a seizure — or during the post-vaccine fever that may itself be a seizure trigger — depletes the metabolic resource the brain most needs to recover from that event.

The specific pattern documented in the vaccine-seizure literature: a child receives a vaccine, develops fever, receives acetaminophen for the fever, and either seizes or develops a pattern of escalating seizure activity. The acetaminophen is not a seizure trigger per se — the question is whether glutathione depletion in a brain already under adjuvant-induced neuroinflammatory stress removes the buffer that was containing the neurological response.

The same principle applies to over-the-counter antihistamines, decongestants, and combination cold/flu medications given to children with seizure disorders. In a brain with a low seizure threshold, the assumption that OTC medications are "safe" because they don't require a prescription deserves scrutiny. None of the products below are listed on any standard neurology discharge sheet. Every one of them belongs in the conversation.

OTC Medications That Affect Seizure Threshold — A Parent Reference

For children and adults with any seizure disorder. Check every product before giving. Combination products are the highest risk — they stack multiple mechanisms simultaneously.

Product / IngredientFound InConcern for Seizure Disorders
AcetaminophenTylenol, Tylenol PM, NyQuil, Dayquil, Excedrin, most "children's" fever reducersDepletes glutathione — the brain's primary antioxidant. Given after a seizure it removes the buffer the brain needs to recover. Hidden in dozens of combination products.
DiphenhydramineBenadryl, ZzzQuil, Unisom, Tylenol PM, Nyquil (some formulas), Motrin PMAnticholinergic; documented GABAergic system interactions. Lowers seizure threshold in sensitive individuals. The most common OTC sleep aid given to children — and one of the highest-risk ingredients in this category.
Dextromethorphan (DXM)Robitussin DM, NyQuil, Mucinex DM, Delsym, most "DM" cough syrupsNMDA receptor antagonist. Directly modulates the same receptor system involved in seizure generation. At standard doses in a seizure-prone brain the interaction is unpredictable.
Pseudoephedrine / PhenylephrineSudafed, DayQuil, many sinus/cold productsSympathomimetic stimulants. Increase neural excitability. Pseudoephedrine has documented seizure-provoking potential. Phenylephrine is the milder oral version now used in most products.
CaffeineExcedrin (65mg/tablet), Anacin, Midol, NoDoz, Vivarin, energy drinks, many headache formulasBlocks adenosine receptors — removing the brain's endogenous anticonvulsant brake. Caffeine withdrawal is also a documented seizure trigger in caffeine-dependent individuals.
ChlorpheniramineChlor-Trimeton, many generic cold/allergy products, Coricidin HBPFirst-generation antihistamine; anticholinergic and CNS-active. Lower risk than diphenhydramine but same class of concern.
Aspartame / artificial sweetenersChildren's liquid medications, chewable tablets, sugar-free formulations — check every liquid medication labelAspartame metabolizes to aspartate — an excitatory amino acid that activates NMDA receptors. Liquid children's medications commonly use aspartame or sucralose as sweeteners. Read the inactive ingredients.
PPIs / Antacids (extended use)Prilosec OTC, Nexium 24HR, Zantac, Tums (high-dose long-term)PPIs deplete magnesium with extended use (FDA Black Box Warning 2011). Magnesium is the physiological brake on the NMDA receptor. Long-term antacid use in a child with seizures is depleting one of the most important seizure-protective minerals.
Combination products — highest risk: NyQuil (acetaminophen + DXM + antihistamine), Tylenol PM (acetaminophen + diphenhydramine), Mucinex DM (DXM), Excedrin (acetaminophen + aspirin + caffeine). These stack multiple mechanisms simultaneously in a single dose.

Questions worth raising with a practitioner: Fever itself is not the emergency for most children with seizure disorders — the combination of fever + glutathione depletion from acetaminophen is the compounding problem. Families managing fever without adding pharmaceutical burden have used tepid water sponging, cool rooms, and hydration — but what's appropriate depends on individual history. For congestion, saline nasal rinse, steam, and positioning are options that don't add excitotoxin or dye load. For sleep difficulty or pain — discuss with a practitioner who knows the seizure history before any OTC use. Read inactive ingredients on every liquid medication. Aspartame, artificial dyes, and propylene glycol are routine additives in children's liquid formulations.

Antibiotics and Seizure Disorders — Not All Carry the Same Risk

When an antibiotic is prescribed for a UTI, a sinus infection, or a skin infection, the prescribing conversation almost never includes seizure history. The choice of antibiotic is treated as interchangeable. For a brain managing a seizure threshold, it is not. Different antibiotic classes carry significantly different neurological risk profiles — and the difference is not disclosed on the standard prescription label.

Avoid / last resort

AntibioticWhy it matters for seizure disorders
FluoroquinolonesCipro, Levaquin, Avelox, Factive, Floxin, Noroxin, BaxdelaDirect GABA-A receptor antagonism; crosses blood-brain barrier; FDA Black Box Warning for seizures and CNS effects; fluoride content adds secondary mechanism; destroys GABA-producing gut bacteria
ImipenemPrimaxinStrongest pro-convulsant in the beta-lactam class; structural GABA-A antagonist; seizure rates as high as 33% in high-dose CNS infection use; usually reserved for severe hospital infections
Metronidazole / TinidazoleFlagyl · TindamaxCNS and cerebellar neurotoxicity; MRI-visible white matter lesions with prolonged use; depletes B vitamins including thiamine (B1) and B6; encephalopathy risk. Tinidazole is the same nitroimidazole class — same neurological risk profile.
Isoniazid (INH)without B6 co-prescriptionPyridoxine (B6) antagonist — B6 is the cofactor for glutamate decarboxylase (GAD), the enzyme that converts glutamate to GABA; B6 depletion shuts down GABA synthesis directly; INH-induced seizures are B6-responsive

Use with caution — dose-adjust for kidney function

AntibioticWhy it matters for seizure disorders
Cephalosporins1st gen: Keflex (cephalexin), Duricef, Ancef (IV)2nd gen: Ceftin, Cefzil, Ceclor3rd gen: Omnicef (cefdinir), Suprax, Rocephin (injection)4th gen: Maxipime (IV/hospital)Beta-lactam structural similarity to GABA → competitive GABA-A antagonism; cephalexin is 90% renally excreted and accumulates in renal impairment; cephalosporin neurotoxicity pattern: encephalopathy → myoclonus → seizures → NCSE. Rocephin (ceftriaxone) is frequently given as a single injection at urgent care — patients often don't realize it belongs to this class.
TMP-SMXBactrim, SeptraFolate antagonism; multiple AED interactions — raises valproate (Depakote) levels and may push lamotrigine (Lamictal); warrants close prescriber communication if on these AEDs

Lower neurological risk — appropriate indications

AntibioticIndication & notes
NitrofurantoinMacrobid, MacrodantinUTI only; concentrates in urine, limited systemic absorption; minimal CNS penetration; not for upper urinary tract or renal impairment
FosfomycinMonurolSingle-dose UTI treatment; minimal CNS effects; no meaningful GABA interaction; well-tolerated option when available
AzithromycinZ-pack, ZithromaxRespiratory/skin infections; short course; note QT prolongation risk if on QT-active AEDs (phenytoin, carbamazepine); minimal GABA-A effect
DoxycyclineVibramycin, Doryx, MonodoxBroad-spectrum; skin, respiratory, tick-borne illness; anti-inflammatory properties may be protective; minimal CNS excitatory effect; preferred over fluoroquinolones for most shared indications
ClindamycinCleocinSkin and soft tissue, dental infections, anaerobes; limited CNS penetration; commonly used as penicillin-allergy alternative in dental procedures; no significant GABA interaction
AmoxicillinAmoxil, TrimoxRespiratory, ear, dental, UTI; lower CNS penetration than cephalosporins at oral therapeutic doses; reasonable starting point when a beta-lactam is indicated

This is not a guide to self-prescribing. It is a guide to an informed conversation: ask which antibiotic is being chosen, why that class, whether alternatives exist, and whether your kidney function has been factored in.

Drugs That Lower Your Seizure Threshold

This is the list every neurologist should hand to every patient before they see another doctor. If you have a seizure disorder — or a child who does — every provider prescribing any medication needs to know this. Most do not check. Most do not ask. The result is that people on anti-seizure medications are routinely prescribed drugs in the categories below without anyone having flagged the interaction. In some cases a single prescription lowers the seizure threshold enough to break through medication control.

This is not a contraindication list — it is a conversation list. The goal is to know what to ask, to make sure the prescribing doctor is aware of your seizure history, and to ask whether a lower-risk alternative exists for the same indication.

Drug / ClassCommon NamesSeizure Threshold Risk
BupropionWellbutrin, Wellbutrin SR, Wellbutrin XL, ZybanAmong the highest seizure risk of all antidepressants; dose-dependent; risk increases sharply above 300mg/day; was temporarily withdrawn from the market after seizure deaths; frequently prescribed for depression, ADHD, and smoking cessation
TramadolUltram, ConZip, RyzoltDirectly lowers seizure threshold via serotonergic and opioid mechanisms; risk multiplies dramatically when combined with SSRIs; frequently prescribed for sports injuries, dental pain, and post-surgical pain — one of the most commonly missed interactions in emergency settings
Fluoroquinolone antibioticsCiprofloxacin (Cipro), Levofloxacin (Levaquin), Moxifloxacin (Avelox)Seizure risk is in the FDA Black Box Warning — yet is rarely disclosed when the prescription is written; fluoroquinolones antagonize GABA-A receptors and block inhibitory neurotransmission; risk is highest in people on AEDs, NSAIDs, or with renal impairment
Antipsychotics (all)Clozapine (highest), Olanzapine, Quetiapine (Seroquel), Haloperidol, RisperidoneAll antipsychotics lower seizure threshold dose-dependently; clozapine is the most potent — it requires seizure monitoring above 600mg/day; frequently co-prescribed with AEDs for mood, anxiety, and psychiatric comorbidities
Tricyclic antidepressantsAmitriptyline (Elavil), Clomipramine (Anafranil), Imipramine (Tofranil), NortriptylineWell-documented seizure threshold lowering — particularly amitriptyline and clomipramine; frequently prescribed for neuropathic pain, migraine prevention, and sleep in people with epilepsy
Carbapenem antibioticsImipenem-cilastatin (Primaxin), Meropenem, ErtapenemImipenem has the highest seizure risk in the class — it reduces valproate levels while simultaneously lowering the seizure threshold; anyone on valproate (Depakote) who is hospitalized and given a carbapenem should have their neurologist notified immediately
Stimulants (high dose or abrupt cessation)Methylphenidate (Ritalin, Concerta), Amphetamine (Adderall, Vyvanse)Frequently co-prescribed with AEDs for ADHD in children with epilepsy; at high doses or during disrupted sleep, stimulants lower the threshold; abrupt discontinuation can cause rebound sleep disruption — an independent seizure trigger
Benzo / alcohol / barbiturate withdrawalXanax, Klonopin, Valium, Ativan; alcohol; phenobarbitalWithdrawal from GABAergic substances is the most dangerous seizure mechanism in this category; withdrawal seizures can occur after as little as 4–6 weeks of regular benzo use; the risk is higher in someone with a pre-existing seizure disorder
ImmunosuppressantsCyclosporine (Sandimmune, Neoral), Tacrolimus (Prograf)Both cause neurotoxicity including seizures, particularly at higher levels; cyclosporine-induced posterior reversible encephalopathy syndrome (PRES) produces seizures as a primary symptom; relevant for transplant patients and autoimmune disease

What to say at every prescribing appointment

"I have a seizure disorder and I am currently taking [medication name]. Before you write this prescription, I need to know: does this medication lower the seizure threshold, and is there an alternative that is less likely to do so?" Write it down. Hand it to the nurse if necessary. A doctor who has not been explicitly told about the seizure history before prescribing has not been given the information they need — and the consequence lands on you, not them.

Vaccines as a Trigger: What the Evidence Shows

Vaccine-related seizures fall into two distinct categories that are often conflated: febrile seizures (fever-triggered, typically benign and self-limiting, occurring 6–14 days post-MMR or within 24 hours post-DTAP) and non-febrile seizure onset that occurs in a temporal window following vaccination. The first category is acknowledged and documented. The second is acknowledged in VAERS data, in the Vaccine Injury Compensation Program payout record, and in case literature — but is not part of the standard risk disclosure at vaccine appointments.

Aluminum adjuvants — present in DTAP, Hepatitis A, Hepatitis B, HPV, and other vaccines — have been shown in animal models to trigger neuroinflammation and to be transported by macrophages to the central nervous system (macrophagic myofasciitis research, Gherardi et al.). Research also suggests aluminum may activate voltage-gated calcium channels in neural tissue — the same channels involved in seizure generation. The specific vulnerability of the developing brain to aluminum-adjuvant neuroinflammation at the timing of the vaccine schedule has not been adequately studied in safety trials designed with neurological outcome endpoints.

For a child who has had a first seizure following vaccination, the temporal correlation deserves the same clinical documentation and seriousness as any other drug-related adverse event. VAERS reports representing the known less-than-1% reporting rate suggest the signal is real. Dismissing temporal correlation as coincidence without investigation is not evidence-based medicine. It is institutional convenience.

FIRES — Febrile Infection-Related Epilepsy Syndrome — is a severe, often refractory epilepsy syndrome that begins with an acute febrile illness (or can follow vaccination) and progresses to a prolonged seizure state requiring ICU admission. It is distinct from common febrile seizures and represents a severe neuroinflammatory process. Outcomes are frequently poor with standard pharmacological management. The neuroinflammatory trigger, not the specific infectious or vaccine agent, is the relevant mechanism.

Cumulative injected aluminum — US childhood schedule, birth through age 12

Midpoint of low/high brand estimates. Source: FDA-approved package inserts.

FDA daily parenteral aluminum threshold for a 3.5 kg newborn: 17.5 mcg — established for IV nutrition, not vaccines.

The 2-month visit alone delivers 680–1,225 mcg in a single encounter — 39 to 70 times the FDA daily parenteral aluminum threshold. No safety trial has evaluated the cumulative adjuvant load of the schedule as a whole.

Full schedule ingredient breakdown — dose by dose →

Hormones, the Menstrual Cycle, and Seizure Threshold

Estrogen is pro-convulsant. Progesterone — specifically via its conversion to the neurosteroid allopregnanolone — is anti-convulsant. Allopregnanolone is a potent positive allosteric modulator of GABA-A receptors, the same receptors targeted by benzodiazepines and phenobarbital. This is established neurochemistry.

Catamenial epilepsy — seizure patterns that cluster around specific phases of the menstrual cycle — is estimated to affect 10–70% of women with epilepsy, depending on the definition used. Three patterns are identified: perimenstrual (seizure increase around menstruation, when progesterone withdraws abruptly), periovulatory (seizure increase around ovulation, when estrogen peaks), and luteal phase inadequacy (decreased seizure threshold throughout the luteal phase due to insufficient progesterone production). The majority of women with catamenial patterns are never asked about their cycle by their neurologist.

Hormonal contraception — which suppresses ovulation and alters estrogen/progesterone ratios — changes seizure frequency in women with catamenial patterns. Some women improve; some worsen. This depends on the progestin type (androgenic progestins have different neurosteroid properties than non-androgenic ones) and on whether natural progesterone cycling is being suppressed. The decision to prescribe hormonal contraception to a woman with a seizure disorder is a neurological decision, not only a gynecological one. It is rarely treated as such.

Ocular Migraines, the Trapezius, and Cortical Spreading

An ocular migraine — visual aura, with or without headache, involving moving geometric patterns, blind spots (scotoma), or kaleidoscope-type visual disturbances — is produced by cortical spreading depression (CSD) in the visual cortex. CSD is a slow, self-propagating wave of electrical depolarization followed by suppression that moves across the cortex at 2–5mm per minute. It is the same type of abnormal electrical event that precedes many focal seizures and occurs during migraine with aura.

CSD and seizure share a lowered cortical excitability threshold. A person who experiences frequent ocular migraines has a visual cortex that is generating abnormal spreading depolarization — the same tissue that, with a slightly different trigger or lower threshold, generates a seizure. They are not the same event. They are neighbors on the spectrum of cortical hyperexcitability.

The trapezius connection: chronic upper trapezius and suboccipital tension compresses the suboccipital triangle — the neurovascular space containing the vertebral arteries, the suboccipital nerve, and the greater occipital nerve. Restriction of vertebral artery flow reduces posterior cerebral circulation. The visual cortex (occipital lobe) is supplied by the posterior cerebral artery — a branch of the vertebral-basilar system. Chronic muscle tension in the upper cervical region can produce measurable reduction in posterior cerebral blood flow sufficient to lower visual cortex excitability threshold, contributing to both ocular migraine frequency and the visual aura prodrome of occipital seizures.

This is why upper cervical chiropractic, craniosacral therapy, and manual release of the suboccipital and trapezius musculature have documented benefit for ocular migraine frequency and for some patients with posterior cortical seizure activity. It is also why any seizure patient with ocular or visual aura symptoms should have their cervical posture, head-forward position, and upper trapezius tension assessed — not just their medications adjusted.

Glucose Regulation and the Seizure Threshold

The brain consumes approximately 20% of the body's total glucose at rest despite comprising only 2% of body weight. Unlike muscle, it has almost no glycogen storage — it depends on continuous glucose delivery from the bloodstream. When blood glucose drops, neuronal excitability increases. When it drops acutely — reactive hypoglycemia following a sugar or refined carbohydrate spike, a skipped meal, or prolonged fasting — the excitatory/inhibitory balance shifts toward hyperexcitability. This is the mechanism by which hypoglycemia causes seizures, and it is the same mechanism by which subclinical glucose instability lowers seizure threshold in individuals who are not hypoglycemic by any clinical definition.

Reactive hypoglycemia is the overlooked pattern: a high-glycemic meal drives a rapid glucose rise, triggering an insulin response that overshoots and drives glucose below the previous baseline 90–120 minutes later. For someone with a seizure disorder, this is a recurring, predictable threshold-lowering event. It is never mapped against seizure timing. It is never eliminated from the dietary recommendations that follow diagnosis.

The glucose-seizure relationship is not only about diabetic or fasting hypoglycemia. It is about the oscillating blood sugar pattern produced by a standard processed-food diet — and the fact that this pattern is never assessed in the context of seizure management.

Continuous glucose monitoring technology can now reveal the reactive hypoglycemic cycles that precede seizures in a subset of patients. This information is clinically available, affordable, and not being used in standard epilepsy care.

The dietary intervention is not a prescription for any particular macronutrient ratio. It is the removal of the instability pattern: eliminate refined sugar and refined carbohydrates, eat real whole food with adequate protein and fat at every meal to slow glucose absorption, and eat consistently without long gaps. The brain needs a stable substrate. The standard diet does not provide one. This is one of the lowest-cost, highest-leverage, most consistently ignored interventions in seizure management. It requires no prescription.

Thiamine and the Brain's Energy Floor

Thiamine — Vitamin B1 — is a cofactor without which the brain cannot convert glucose into energy. It is the essential co-enzyme for pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase — the enzymes that drive glucose into the citric acid cycle to produce ATP in neurons. Without adequate thiamine, neurons cannot meet their energy demands, inhibitory tone degrades, and excitability increases.

The severe deficiency picture is well known: a condition called Wernicke encephalopathy — confusion, ataxia, and seizures — most commonly seen in alcoholism and prolonged starvation. This is the end-stage the medical system recognizes. What it does not recognize is the far more common subclinical insufficiency that impairs neuronal energy metabolism without producing the textbook triad, and that may be present in a significant proportion of people eating a standard processed-food diet.

The depletion loop:

Thiamine is required for glucose metabolism. The more glucose consumed, the more thiamine is burned. A high-carbohydrate processed-food diet creates two simultaneous problems: dysregulated blood glucose demanding constant neuronal compensation, and elevated thiamine demand on a diet that supplies almost none. Processed grains — white flour, white rice — are thiamine-depleted by refining. Heat, sulfite preservatives, and processing all destroy thiamine further. The same diet that destabilizes blood sugar also strips the cofactor the brain needs to run on it.

Additional thiamine depleters: alcohol (destroys intestinal thiamine absorption directly), diuretics (urinary thiamine loss), metformin, prolonged PPI/antacid use, bariatric surgery, raw fish and shellfish (thiaminase enzyme in raw seafood destroys thiamine). Any person with a seizure disorder using any of these — or eating the standard American diet — carries an unquantified thiamine insufficiency that has not been evaluated.

Food sources: pork (particularly pork loin), organ meats (liver, heart), nutritional yeast, sunflower seeds, legumes. The key is removing the inputs that deplete thiamine — processed carbohydrates, sugar, alcohol — while increasing whole-food sources. The neurologist prescribing the anticonvulsant has not asked about this. It belongs in the conversation.

Excitotoxins in the Diet: Exciting Neurons to Death

The word "excitotoxin" was coined by neuroscientist John Olney in 1969 to describe a class of compounds that stimulate neurons so intensely and persistently that the neurons are damaged or destroyed. The mechanism is direct: excitatory amino acids — primarily glutamate and aspartate — bind to NMDA and AMPA receptors on neurons, causing calcium influx, mitochondrial failure, oxidative stress, and cell death. This is the same downstream pathway as seizure-induced excitotoxicity. Adding dietary excitotoxins to a brain that already generates excess glutamate during seizures is not a neutral act.

Russell Blaylock's landmark work — Excitotoxins: The Taste That Kills (1994) — documented the neurological mechanisms of MSG and aspartame in detail accessible to clinicians and the public. The food industry's response was to rename the compounds, not remove them.

Monosodium glutamate (MSG) is free glutamic acid — the excitatory neurotransmitter itself, in free, unbound form, delivered directly to the gut and absorbed into the bloodstream. Bound glutamate in whole food (meat, cheese, tomatoes) is released slowly during digestion. Free glutamate from MSG and its derivatives crosses into neural tissue rapidly and at concentrations that whole food never produces (Olney JW, Science, 1969).

The FDA classifies MSG as "generally recognized as safe." It also does not require MSG to be labeled as MSG when it is present in a compound ingredient. The result: MSG and free glutamate are present in the processed food supply under dozens of names that do not say "MSG" on the label.

Hidden names for free glutamate in food:

The full list and mechanism are covered on the MSG & Excitotoxins page.

Aspartame — the artificial sweetener in diet sodas, sugar-free products, and thousands of processed foods — breaks down in the body into aspartate, phenylalanine, and methanol. Aspartate is a second major excitatory amino acid. Like free glutamate, it drives NMDA receptor activation. Aspartame is documented to lower seizure threshold in animal models. Multiple published case reports describe seizure onset or worsening following aspartame consumption, with resolution or improvement on removal. The medical literature on this is not large. It is not nothing.

For a person with a seizure disorder, the elimination of processed food containing free glutamate, MSG derivatives, and aspartame is not a fringe intervention. It is the removal of compounds that directly activate the same receptor pathway responsible for seizure-induced neuronal death. It costs nothing. It is not on any neurology discharge instruction sheet.

Insulin — Not Just Glucose

The standard glucose conversation stops at blood sugar. The more important variable is insulin. The brain is an insulin-sensitive organ — neurons require insulin signaling for glucose uptake, synaptic function, and neuroprotection. When insulin resistance develops in the brain, neurons become unable to take up glucose efficiently even when blood glucose levels appear normal on a standard panel. The neuron is starving while the blood test looks fine.

Hyperinsulinemia — chronically elevated insulin from a diet the pancreas is constantly compensating for — drives neuroinflammation directly. Insulin resistance in the brain is now the proposed mechanism for Alzheimer's disease, increasingly referred to in research as Type 3 diabetes. Neuroinflammation elevates glutamate, impairs GABA function, and lowers seizure threshold. A seizure workup that checks fasting glucose and HbA1c but not fasting insulin is missing the primary metabolic driver.

The tests that are not being ordered:

  • — Fasting insulin — not fasting glucose. Insulin rises years before glucose does. A fasting insulin above 5–7 µIU/mL signals compensatory hyperinsulinemia even with normal fasting glucose.
  • — HOMA-IR — calculated from fasting glucose and fasting insulin. Quantifies insulin resistance. Optimal below 1.0; above 2.0 is significant resistance.
  • — Glucose + insulin response curve — how much insulin is released in response to a glucose load. Standard glucose tolerance testing without simultaneous insulin measurement misses hyperinsulinemic response to normal glucose.
  • — Ferritin and iron studies — see below. Iron and insulin resistance co-occur and compound each other's neurological damage.

The seizure-prone brain operates at a metabolic disadvantage. Adding insulin resistance to that equation means neurons that are underpowered, inflamed, and unable to produce sufficient inhibitory tone — not because of a genetic epilepsy syndrome, but because of a diet-driven metabolic state that is reversible and has never been assessed.

Iron Dysregulation and Cortical Irritability

Iron is essential to neurological function and catastrophic in excess. The brain has the highest iron concentration of any organ outside the liver. Neurons depend on iron for myelination, neurotransmitter synthesis, and mitochondrial function. Excess free iron — iron not bound to ferritin or transferrin — drives Fenton chemistry: the same hydroxyl radical cascade documented in oxidative carcinogenesis. In neurons, this means oxidative DNA damage, lipid peroxidation of cell membranes, mitochondrial failure, and — in the specific context of cortical neurons with already-compromised excitatory/inhibitory balance — heightened irritability and lowered seizure threshold.

Post-traumatic hemosiderin deposits — iron released from lysed red blood cells after a brain bleed — are a documented cause of cortical irritation and post-traumatic epilepsy. The iron mechanism connecting head injury to delayed seizure onset is established in the literature. Every head injury that caused any bleeding deposits iron into cortical tissue. That iron generates free radicals indefinitely.

High-dose iron supplementation — routinely prescribed for anemia without iron studies confirming the type of anemia — introduces systemic iron that can accumulate in neural tissue. Children given iron supplements without confirmed iron-deficiency anemia are receiving a pro-oxidant with known neurological consequences. Ferritin is the storage form: high ferritin indicates iron overload. Low ferritin indicates depletion. Serum iron alone is not sufficient. A full iron panel — serum iron, ferritin, TIBC, transferrin saturation — is the minimum workup before any iron supplementation, and it is rarely done before prescribing.

Hormonal context: estrogen increases iron retention. Women in the reproductive years who are also on hormonal contraception — which elevates estrogen-driven iron retention — and who have a seizure disorder have a compounding iron/estrogen/excitotoxicity picture that is essentially never mapped. Ferritin should be part of any seizure workup in women.

The Cofactors That Govern Iron — Almost Never Assessed Together

Iron does not regulate itself. It depends on a network of mineral and nutrient cofactors for proper transport, storage, and export. Deficiency in any of these creates the conditions for iron accumulation — including in the brain. None of these relationships are factored into standard iron supplementation prescribing or seizure disorder workups.

Brain iron accumulation is not only a post-traumatic phenomenon. It increases with age, accumulates in the substantia nigra, globus pallidus, and hippocampus — the latter being the structure most commonly involved in temporal lobe seizure generation. Susceptibility-weighted MRI (SWI) can detect cortical and subcortical iron deposits. Routine epilepsy evaluation rarely includes it. A person with decades of processed food eating, chronic dehydration with demineralized water, high iron intake without copper and zinc balance, and a history of minor head trauma may have meaningful cortical iron accumulation that has never been imaged.

The practical question is not "does this person have iron deficiency anemia" — it is "does this person have dysregulated iron metabolism that is generating free radicals in their brain?" These are different questions requiring different tests: a full iron panel (serum iron, ferritin, TIBC, transferrin saturation), serum copper, ceruloplasmin, zinc, and retinol. Ordered together, once, they tell a story that isolated ferritin testing cannot.

Head Injury, Sport, and Post-Traumatic Seizures

Post-traumatic epilepsy (PTE) is a documented syndrome: seizures that develop following traumatic brain injury, sometimes immediately, more often months to years after the event. PTE accounts for approximately 20% of symptomatic epilepsy in the general population. In severe penetrating TBI, the rate approaches 50%. In mild TBI — the concussions and subconcussive impacts that are never diagnosed — the rate is lower but the cumulative population exposure is vastly larger.

The mechanism: traumatic injury causes focal bleeding, disrupts the blood-brain barrier, deposits hemosiderin (iron) in cortical tissue, triggers neuroinflammation, and damages the inhibitory interneurons that regulate excitability. Each of these changes — iron deposition, neuroinflammation, interneuron loss — persists long after the acute injury resolves. The latency period between injury and first seizure can be years. A person developing new-onset epilepsy at 35 who played contact sports through their 20s has a relevant history that standard neurology intake forms rarely capture.

Contact sport mechanisms that are not being discussed:

Contact sport mechanisms that are not being discussed: Heading a soccer ball: A soccer ball traveling at 50–70 mph delivers a subconcussive force equivalent to a mild TBI each time it is headed. Elite players head the ball 6–12 times per match. Amateur players head far more in training drills. FIFA's own research (Lipton et al., 2013, Radiology) documented white matter abnormalities on diffusion tensor imaging in soccer players correlating with heading frequency — below the threshold of any diagnosed concussion. Cumulative subconcussive trauma is now the primary mechanism proposed for CTE. It is also a mechanism for delayed post-traumatic epilepsy. Whiplash: Rapid flexion-extension of the cervical spine stretches and tears axons in the cervical cord and brainstem. It compresses the suboccipital triangle, injures the vertebral arteries, and can cause microhemorrhages in the posterior fossa. The posterior circulation supplies the temporal and occipital lobes — the two brain regions most commonly involved in focal seizure activity. Whiplash from a rear-end collision is dismissed as a soft-tissue injury. Its neurological consequences — including seizure onset months later — are rarely attributed to it. Football, rugby, martial arts, boxing: The impact biomechanics vary; the result is the same — cumulative subconcussive and concussive trauma depositing iron in cortical tissue, disrupting inhibitory interneuron networks, and leaving a brain with a permanently lowered threshold. The latency period means the sport is often not in the history by the time the seizure appears.

The history that is not being taken:

"Did you play contact sports? For how many years? Did you ever head a ball? Have you had whiplash? Have you been in a motor vehicle accident? Did you ever have a concussion that went undiagnosed?" These questions are not on the standard neurology intake form. They are not asked. A person who played soccer from age 8 to 22, headed balls thousands of times in practice, and never had a formally diagnosed concussion does not have a "negative head injury history" — they have a history that was never collected.

The link between head injury and seizures is well established in the severe TBI literature. What is not established in clinical practice is the extension of that question to subconcussive sport, whiplash, and the long latency window between exposure and onset. For a full treatment of TBI mechanisms, recovery, and the neurological consequences of cumulative head trauma, see the TBI & Concussion page.

Upper Cervical Structure and the Brainstem

If you have a history of head injury, sport concussion, whiplash, or birth trauma — including forceps, vacuum extraction, or rapid delivery — the structural relationship between the upper cervical spine (C1–C2) and the brainstem is relevant to your seizure history. Upper cervical misalignment compresses cerebrospinal fluid (CSF) flow, reduces vertebral artery patency — the blood supply to the posterior brain and brainstem — and creates persistent mechanical tension on brainstem structures that regulate arousal, respiration, and seizure threshold. This structural dimension is outside the standard neurology workup.

For occipital symptoms, visual aura, or posterior focal seizures in particular, the upper cervical structural relationship is worth evaluating. Non-forceful structural modalities address this specifically. Craniosacral therapy works directly with CSF pressure and the dural membrane system — the connective tissue that surrounds and tethers the brain and spinal cord. Applied kinesiology evaluates structural, nutritional, and neurological function together through muscle testing. Quantum neurology works with the nervous system's own signaling to assess and restore neurological function. None of these approaches use machines, lights, or biofeedback devices.

For upper cervical correction specifically, Blair technique and NUCCA are the low-force options — both use precise pre-adjustment imaging and minimal, targeted contact at C1–C2, not the broad manipulation of general spinal adjustment. The goal is structural decompression that removes chronic brainstem tension — not a forceful or aggressive intervention.

See the TBI & Concussion page for the full structural picture, including birth mechanics and their long-term neurological consequences.

Sleep, Mouth Breathing, and Airway

Sleep deprivation is the single most potent modifiable seizure trigger in the literature. But the conversation about sleep almost never goes deeper than hours. The quality of sleep — specifically whether it is restorative, oxygen-sufficient, and architecturally intact — is determined in large part by how the person breathes during it. Mouth breathing during sleep is a structural and neurological problem that standard seizure management does not assess.

Nasal breathing produces nitric oxide in the paranasal sinuses — a vasodilator that improves oxygen delivery to the brain and regulates vascular tone. Mouth breathing bypasses this entirely. It also disrupts the CO₂/O₂ balance that regulates respiratory drive, leading to over-breathing and reduced oxygen delivery at the cellular level despite normal oxygen saturation on a pulse oximeter. The brain receives less oxygen, produces more neuroinflammatory byproducts overnight, and enters the morning in a higher excitability state.

Obstructive sleep apnea (OSA) and seizure disorders share a bidirectional relationship that is rarely addressed. OSA causes repeated overnight hypoxic episodes — oxygen drops, the brain activates a stress response, sleep architecture fragments. Each hypoxic episode is a neurological stressor that lowers seizure threshold. Conversely, nocturnal seizures can mimic apneic episodes on a sleep study, and the two can be difficult to distinguish without simultaneous EEG. A person with undiagnosed OSA whose nocturnal events are seizures — or whose seizures are being worsened by concurrent OSA — may be treated for one while the other goes unidentified.

Dry mouth on waking is a direct indicator of mouth breathing during sleep. It is a symptom that is universally reported, universally dismissed, and never connected to seizure management in the standard clinical encounter. Waking with a dry mouth means spending the night mouth breathing — impaired nitric oxide production, reduced CO₂ regulation, and fragmented sleep architecture. Every night.

Tonsils and adenoids are the primary structural reason children mouth breathe. Enlarged tonsils and adenoids narrow the upper airway, making nasal breathing insufficient during sleep and forcing mouth breathing as a compensatory pattern. The long-term consequences — altered jaw and palate development, chronic mouth breathing, sleep-disordered breathing — are well documented. Tonsil removal is the most common surgical procedure in children. What is not discussed is that post-tonsillectomy, the mouth-breathing pattern established during years of obstruction does not automatically resolve. The structural correction does not retrain the breathing habit.

For children with seizure disorders: the question of tonsil and adenoid status, sleep position, snoring, dry mouth, and observed apneic episodes during sleep is part of the relevant history — and it is outside the standard neurology intake. A sleep study without simultaneous EEG, or an EEG without a sleep study, is an incomplete picture in a child with nocturnal events.

The intervention starts with the simplest available assessment: does the person wake with a dry mouth? Do they snore? Has anyone observed pauses in their breathing during sleep? Does the child sleep with their mouth open? These questions cost nothing. The answers direct everything else.

Sleep Position, Glymphatic Clearance, and SUDEP

During deep slow-wave sleep, the brain activates a macroscopic waste-clearance pathway called the glymphatic system. The interstitial space between brain cells expands by roughly 60% — reducing resistance to fluid flow — and cerebrospinal fluid flushes through the brain tissue, clearing out accumulated neurotoxic proteins, excess glutamate, potassium ions, and lactic acid. This process is the brain's overnight maintenance cycle. It fails during sleep deprivation, is compromised by alcohol at high doses, and is critically dependent on sleep position.

Sleeping on your side (lateral decubitus position) produces significantly more efficient glymphatic clearance than supine or prone positions. Sleeping prone — face down — is the worst: fluid tracer studies show dramatically reduced interstitial clearance and retention of metabolic waste in the prone posture.

Sleep position and SUDEP: what the MORTEMUS study found

The MORTEMUS study monitored epilepsy unit patients who died from SUDEP (Sudden Unexpected Death in Epilepsy) with continuous cardiorespiratory recording. In 71% of fatal cases, the patient was found in a prone (face-down) sleeping position. The pattern was consistent: a nocturnal convulsion, followed by terminal respiratory arrest, with the patient face-down — airway obstructed, glymphatic clearance halted, brainstem unable to clear the massive glutamate surge the seizure produced.

SUDEP kills 1,100–1,500 people in the US per year. Prone sleeping is not a minor variable. Sleeping on the side is the practical intervention — and it is almost never discussed in neurology appointments.

The mechanism is direct: a nocturnal convulsion produces a surge in extracellular glutamate and potassium. These need to be cleared by the glymphatic system during the post-ictal recovery phase. Prone posture impairs this clearance, allows neurotoxic accumulation in brainstem regulatory areas, and contributes to the respiratory arrest that defines most SUDEP deaths. Airway obstruction in the prone position compounds this — post-ictal hypoventilation plus face-down airway collapse is the terminal sequence.

For anyone with a seizure history: sleeping on the side is a specific, mechanistically grounded intervention. For parents of children with seizures: lateral positioning and a firm, flat mattress are the simplest structural modifications for nocturnal safety. These questions fall outside standard neurology care.

Fluoride — A Neurotoxin in the Water Supply

In 2024, the National Toxicology Program (NTP) completed the most comprehensive meta-analysis ever conducted on fluoride and neurodevelopmental outcomes — 72 studies, 64 of which found an inverse association between fluoride exposure and IQ. The NTP concluded with moderate confidence that fluoride is associated with lower IQ in children at doses that overlap with current US water fluoridation levels. This was published by the National Institutes of Health. It is not fringe science.

For a brain with a seizure disorder — already working against a compromised excitability threshold — fluoride is not a neutral bystander. Its mechanisms are directly relevant.

Fluoride concentration — where you encounter it daily

Research has linked exposure above 2 ppm to neurodevelopmental effects (NTP, Environ Health Perspect, 2024, doi:10.1289/EHP13469). The 2024 NTP meta-analysis found effects at concentrations overlapping US water fluoridation levels.

How Fluoride Affects the Brain

  • Pineal gland calcification. The pineal gland, which produces melatonin to regulate the circadian rhythm and sleep, accumulates fluoride at higher concentrations than any other soft tissue — exceeding even bone in some studies. Calcification of the pineal gland is visible on routine brain scans and is treated as a normal finding. It reduces melatonin production. Reduced melatonin → disrupted sleep → lower seizure threshold.
  • Thyroid disruption. Fluoride competes with iodine for uptake via the sodium-iodide symporter (NIS), reducing thyroid hormone synthesis. Thyroid hormones regulate GABA receptor density, voltage-gated sodium channel expression, and overall neural excitability. Fluoride-induced hypothyroidism — documented at doses within the exposure range of fluoridated water — creates a hormonal environment that is permissive for increased cortical excitability.
  • Cholinesterase inhibition. Fluoride inhibits acetylcholinesterase, the enzyme that breaks down acetylcholine (ACh) at the synapse. Elevated ACh increases neuronal firing rate. In a brain with a low seizure threshold, additional excitatory cholinergic signaling is not trivial.
  • Mitochondrial disruption. Fluoride has been shown to inhibit cytochrome c oxidase (Complex IV), the terminal enzyme of the mitochondrial electron transport chain — the same enzyme that powers neuronal energy production and that is activated by red and near-infrared light from the sun. Mitochondrial dysfunction in neurons reduces the energy available to maintain inhibitory tone. The brain's ability to inhibit itself is an energy-dependent process. Anything that reduces neuronal ATP availability shifts the balance toward excitation.
  • Blood-brain barrier penetration. Fluoride crosses the blood-brain barrier readily. This is not disputed. The debate is about dose — but for a brain already in a vulnerable state, the question of threshold should be asked differently than for a healthy brain with no seizure history.

Fluoride is eliminated primarily through the kidneys. In children and individuals with impaired kidney function, accumulation is faster and clearance is slower. Fluoride exposure in the US comes from drinking water (fluoridated at 0.7 mg/L), from foods processed with fluoridated water (which includes most packaged and restaurant food), and from toothpaste ingestion — particularly significant in children under 6 who cannot reliably spit.

The child with a seizure disorder who brushes their teeth with fluoride toothpaste twice a day, drinks fluoridated tap water, eats packaged food, and lives in a fluoridated municipality is receiving continuous low-level fluoride exposure in a brain that cannot afford additional neurological burden. The neurologist managing their seizures has almost certainly never asked about water source, toothpaste type, or dietary fluoride load. For the full picture on fluoride mechanisms and exposure reduction, see the Fluoride page.

Ready to go deeper?

Fellowship opens the door to personal ministry support from Rev. Allie — applied to your specific path.

Enter into Fellowship